Skip to main content
. 2021 Sep 14;16(9):e0257424. doi: 10.1371/journal.pone.0257424

Table 2. Consumption of different pharmacological sub-groups of antibacterials in the country and public and private sectors.

ATC code ATC level 3 classification of ABAs ABA consumption volume in DDD per million DDD per 1000s population
Public sector (%) Private sector (%) Total (%)
J01A Tetracycline’s 5.94 (6.06) 14.89 0.01 20.83 (6.04) 0.98
J01B Amphenicols 0.00 (0.00) 0.19 5.90 0.19 (0.06) 0.01
J01C Beta-lactam antibacterials, penicillins 57.38 (58.57) 67.80 2.62 125.18 (36.31) 5.90
J01D Other Beta-lactam antibacterials 13.38 (13.66) 42.20 0.10 55.58 (16.12) 2.62
J01E Sulfonamides and trimethoprim 0.50 (0.51) 1.71 3.22 2.21 (0.64) 0.10
J01F Macrolide, lincosamide and streptogramins 7.69 (7.78) 60.57 0.01 68.26 (19.80) 3.22
J01G Aminoglycoside antibacterials 0.14 (0.14) 0.00 2.51 0.14 (0.04) 0.01
J01M Quinolone antibacterials 6.66 (6.82) 46.57 0.90 53.23 (15.44) 2.51
J01X Other antibacterials 6.28 (6.41) 12.84 16.26 19.12 (5.55) 0.90
Total 97.96 100.00 246.76 0.98 344.72 100.00 16.26